2020 Southwest Prostate Cancer Symposium 

Agenda

The virtual 2020 Southwest Prostate Cancer Symposium offers a robust online program with two multi-track sessions, including CME lectures, panels virtual hands-on training demonstrations,networking and more. Join us for the full virtual conference broadcast on Saturday, December 12, 2020, from 8:00am-5:30pm (EST).

Saturday, December 12, 2020

(ALL TIMES IN EASTERN TIME ZONE)

Welcome and Introduction
Program Co-Chairs: Nelson N. Stone, MD, and Richard G. Stock, MD

SESSION 1 – Identifying Candidates for Focal Therapy

Pathologist’s Perspective
M. Scott Lucia, MD   

Transrectal mpMRI Fusion Biopsy
Leonard S. Marks, MD

Freehand Transperineal Prostate Biopsy Under Local Anesthesia
Michael A. Gorin, MD

Can One Biopsy Event Identify Focal Therapy Candidates?
Nelson N. Stone, MD

Application of MRI Fusion Biopsy Results to Focal Therapy
Leonard S. Marks, MD

Panel Discussion
Moderator: Nelson N. Stone, MD

Exhibits and Networking

SESSION 2 – Limiting Radiation Injury

Does Anatomic Rectal Displacement Improve Dosimetry and Reduce Injury?
Jon S. Prescott, MD

Radiation Dose Requirements for Local Disease Eradication
Nelson N. Stone, MD

Brachytherapy and Focal Therapy Outcomes
Richard G. Stock, MD

Panel Discussion
Moderator: Richard G. Stock, MD

Spotlight Product Theaters

Spotlight Product Theater 1
Important Evidence-Based Changes in the Metastatic
Castration-Sensitive Prostate Cancer Treatment Landscape
Speaker: Edward M. Uchio, MD, FACS, CPI
Sponsored by Astellas Pharma US and Pfizer Oncology

Spotlight Product Theater 2
Erleada: TITAN and New Data for SPARTAN Final Analysis
Speaker: Matthew B. Rettig, MD
Supported by Janssen Biotech

Spotlight Product Theater 3
An Innovative Abiraterone Acetate, YONSA®
Speaker: Raoul S. Concepcion, MD
Sponsored by Sun Pharma

SESSION 3 – Virtual Hands-on Training

Office-Based and Transperineal mpMRI Fusion Biopsy
Michael A. Gorin, MD

Transrectal mpMRI Fusion Biopsy
Leonard Marks, MD

Transperineal Hydrogel Placement
Jon S. Prescott, MD

Brachytherapy Focal Therapy Technique
Richard G. Stock and Nelson N. Stone

Panel Discussion and Closing Remarks
Nelson N. Stone, MD

CME Information

ACCREDITATION/CREDIT DESIGNATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical College of Wisconsin (MCW) and Carden Jennings Publishing Co., Ltd. (CJP). The Medical College of Wisconsin (MCW)  is accredited by ACCME to provide continuing medical education for physicians.

MCW designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

TARGET AUDIENCES
This activity is designed for radiation oncologists, urologists, medical oncologists, primary care specialists, and other healthcare professionals involved in the diagnosis and management of prostate cancer.

EDUCATIONAL OBJECTIVES
At the conclusion of the activity, participants should be able to:

• Assess which diagnostic tests help distinguish a lower versus higher-risk patient
• Recognize how the decrease in early detection has resulted in prostate cancers presenting at a more advanced stage
• Describe technical advances, including robotic radical prostatectomy, image-guided external beam radiotherapy (IGRT), proton beam therapy, hypofractionated radiotherapy (SBRT), computer-guided brachytherapy, and mpMRI, and demonstrate their role in prostate cancer treatment and detection
• Identify appropriate patients for radiation-based treatments such as brachytherapy, brachytherapy boost, IMRT/IGRT, proton therapy robotic and open prostatectomy, and focal therapy taking serum and genetic influences into account
• Assess the implications of local failure after radiation therapy and introduce new radio-protective technologies
• Discuss treatment of advanced disease, specifically in the non-metastatic CRPC disease state
• Contribute to group discussions regarding potential future research directions to address how we can improve inter-observer agreement and overall quality, develop machine-learning techniques, and improve current technology for staging high-risk disease and for disease monitoring after therapy.

EDUCATIONAL METHODS
Lectures | Debates | Question and Answer Sessions | Panel Discussions | Live Surgical Case Demonstrations

EVALUATION
Evaluation by questionnaire will address program content, presentation, and possible bias.

Registration

During these times, Grand Rounds in Urology and the Southwest Prostate Cancer Symposium are committed to you and helping your practice run as best as it can.